Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Lundbeck Posts Promising Phase IIb Data For Bocunebart In Migraine Prevention
Feb 13 2026
•
By
Sushmita Panda
Migraine is a neurological disorder characterized by recurring moderate to severe, throbbing headaches.
(Shutterstock)
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D